Stay updated on Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe change updates the page revision from v3.4.1 to v3.4.2, with no observed changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. This update does not affect study information or user-facing content.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page now displays 'Last Update Posted' instead of 'Last Update Posted (Estimated)', removing the estimated tag from the update timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedA new 'Last Update Posted (Estimated)' field was added and the revision label updated to 'v3.3.4', replacing the previous 'Last Update Posted' field and 'Revision: v3.3.3'.SummaryDifference0.1%

- Check48 days agoChange DetectedThe Locations section was updated to show 11 locations, and the Miami Cancer Institute site was removed from the list.SummaryDifference0.4%

- Check55 days agoChange DetectedStudy Record Dates show additions of newer date entries (e.g., 2025-12-31 and 2025-12-29) and removals of earlier timestamps (e.g., 2025-09-09 and 2025-09-08).SummaryDifference0.3%

Stay in the know with updates to Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.